NCT04993469 Patient Reported Outcome on Genital Sensitivity and Sexual Function After Genital Gender Affirming Surgery
| NCT ID | NCT04993469 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Ghent |
| Condition | Gender Dysphoria |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2021-05-27 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2021-05-27 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
For genital gender affirming surgery, it remains unclear to what extent genital sensitivity might be expected and what the impact of this might be on sexual functioning.
Eligibility Criteria
Inclusion Criteria: * Voluntarily signed written informed consent according to the rules of Good Clinical Practice (Declaration of Helsinki) and national regulations * Patient age ≥ 18 years * Transgender male, female of gender non-conforming patient with diagnosed gender dysphoria and the specific wish to undergo genital gender affirming surgery * Fit for operation, based on the surgeon's expert opinion * Patient is able and willing to attend the follow-up consultations Exclusion Criteria: * Absence of signed written informed consent and thus a patient unwilling to participate. * Patient age \< 18 years * Cisgender patients * Patients unfit for operation * Patient declares that it will be impossible for him to attend the follow-up consultations
Frequently Asked Questions
Who can join the NCT04993469 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 110 Years, studying Gender Dysphoria. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04993469 currently recruiting?
Yes, NCT04993469 is actively recruiting participants. Visit ClinicalTrials.gov or contact University Hospital, Ghent to inquire about joining.
Where is the NCT04993469 trial being conducted?
This trial is being conducted at Ghent, Belgium.
Who is sponsoring the NCT04993469 clinical trial?
NCT04993469 is sponsored by University Hospital, Ghent. The trial plans to enroll 200 participants.